(Q35163567)

6 August 2017

1 reference

title

The enteric nervous system III: a target for pharmacological treatment (English)

1 reference

6 August 2017

Mark Berner Hansen

1

1 reference

6 August 2017

1 July 2003

1 reference

Basic and Clinical Pharmacology and Toxicology

6 August 2017

1 reference

6 August 2017

93

1 reference

6 August 2017

1

1 reference

6 August 2017

1-13

1 reference

Treatment of irritable bowel syndrome: a review of randomised controlled trials

6 August 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

Gastrointestinal perception: pathophysiological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

Effects of a serotonin 5-HT(4) receptor antagonist SB-207266 on gastrointestinal motor and sensory function in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

Effects of inflammatory mediators on gut sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

Enteric nervous system disorders: genetic and molecular insights for the neurogastroenterologist

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

Clinical perspectives, mechanisms, diagnosis and management of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

Efficacy of alosetron in irritable bowel syndrome: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

Safety and tolerability of tegaserod in patients with irritable bowel syndrome and diarrhea symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

Electrophysiological studies of 5-hydroxytryptamine receptors on enteric neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

Ligand-gated ion channels in the enteric nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

Sensory-motor responses to volume-controlled duodenal distension

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

Review article: roles played by 5-hydroxytryptamine in the physiology of the bowel

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

Recent and forgotten aspects of visceral pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

Expression of 5-HT3 receptors in the rat gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

Sensory neurone responses to mucosal noxae in the upper gut: relevance to mucosal integrity and gastrointestinal pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

5-HT receptor classification and nomenclature: towards a harmonization with the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

Identification of cells that express 5-hydroxytryptamine1A receptors in the nervous systems of the bowel and pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

Effect of the selective serotonin reuptake inhibitor sertraline on gastric sensitivity and compliance in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

The participation of galanin in pain processing at the spinal level

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

Impaired synthesis or cellular storage of norepinephrine, dopamine, and 5-hydroxytryptamine in human inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

Patients with constipation-predominant irritable bowel syndrome (IBS) may have elevated serotonin concentrations in colonic mucosa as compared with diarrhea-predominant patients and subjects with normal bowel habits

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

Sensory and biomechanical responses to distension of the normal human rectum and sigmoid colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

Development of pharmacological agents for targeting neurotrophins and their receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

Serotonin type-4 receptors modulate the sensitivity of intramural mechanoreceptive afferents of the cat rectum

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

Review article: gastrin and colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

Compliance, tone and sensitivity of the rectum in different subtypes of irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

5-HT7 receptors: current knowledge and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

Alosetron improves quality of life in women with diarrhea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

Gut perception in humans is modulated by interacting gut stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

Emerging treatments for irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

Development of the enteric nervous system

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

Impaired drinking capacity in patients with functional dyspepsia: relationship with proximal stomach function

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

Mediators and pharmacology of visceral sensitivity: from basic to clinical investigations

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

Pathobiology of visceral pain: molecular mechanisms and therapeutic implications. III. Visceral afferent pathways: a source of new therapeutic targets for abdominal pain.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

Management of the irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

Rectal antinociceptive properties of alverine citrate are linked to antagonism at the 5-HT1A receptor subtype

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

Irritable bowel syndrome: new agents targeting serotonin receptor subtypes

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

The kappa agonist fedotozine relieves hypersensitivity to colonic distention in patients with irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

A 5HT3 antagonist corrects the postprandial colonic hypertonic response in carcinoid diarrhea.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

Irritable bowel syndrome: how far do you go in the workup?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

Serotonin and the 5-HT(2B) receptor in the development of enteric neurons.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

Role of PAR2 in pain and inflammation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

Serotonin 5-HT3 and 5-HT4 receptor antagonists

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

Structural abnormalities of the nervous system in Crohn's disease and ulcerative colitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

The enteric nervous system

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

Effect of the 5-HT1 agonist sumatriptan on oesophageal motor pattern in patients with ineffective oesophageal motility

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

Towards a reduction of rectal pain?

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

The diversity in the vanilloid (TRPV) receptor family of ion channels

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

The enteric nervous system I: organisation and classification

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

The enteric nervous system II: gastrointestinal functions

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

Attenuation of hydrophobic phospholipid barrier is an early event in Helicobacter felis-induced gastritis in mice

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

Pathophysiology of gastrointestinal hormones. Implications for paediatrics

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

Cilansetron acts at its site of absorption to antagonize the sensitivity of mesenteric afferent fibres to 5-hydroxytryptamine in the rat jejunum

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

Inhibition of neurotensin-induced pancreatic carcinoma growth by a nonpeptide neurotensin receptor antagonist, SR48692

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

The case for gastrin-releasing peptide acting as a morphogen when it and its receptor are aberrantly expressed in cancer

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

Hirschsprung disease and other enteric dysganglionoses

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

Receptors and transmission in the brain-gut axis: potential for novel therapies. I. Receptors on visceral afferents

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

Immunocytochemistry of serotonin-containing nerves in the human gut

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

Review article: clinical pharmacology models of irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

Effect of cisapride on gastric sensitivity to distension, gastric compliance and duodeno-gastric reflexes in healthy humans

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

Neurotensin and a non-peptide neurotensin receptor antagonist control human colon cancer cell growth in cell culture and in cells xenografted into nude mice

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

Basic and clinical aspects of visceral hyperalgesia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

Cellular and molecular mechanisms involved in the development of the enteric nervous system.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

Differential distribution of serotonin and tryptophan hydroxylase in the human gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

Enteric nervous system: development and developmental disturbances--part 1.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

Serotonin reuptake inhibitors fluoxetine and citalopram relax intestinal smooth muscle

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

Activation of intrinsic afferent pathways in submucosal ganglia of the guinea pig small intestine

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

Duplex ultrasound for assessment of superior mesenteric artery blood flow

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

Neurotransmitter coding of enteric neurones in the submucous plexus is changed in non-inflamed rectum of patients with Crohn's disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

Comparative study of serotonin and bombesin in adenocarcinomas and neuroendocrine tumors of the colon

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

Enteric neuropathophysiology and inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

Large-scale ambulatory study of postprandial jejunal motility in irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

Effects of intracolonic opioid receptor agonists on polymodal pelvic nerve afferent fibers in the rat.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

Cyclooxygenase 2: a molecular target for cancer prevention and treatment

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

Review article: 5-hydroxytryptamine agonists and antagonists in the modulation of gastrointestinal motility and sensation: clinical implications

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

G17DT--a new weapon in the therapeutic armoury for gastrointestinal malignancy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

Enteric nervous system, serotonin, and the irritable bowel syndrome.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2003.930101.X

7 January 2021

10.1034/J.1600-0773.2003.930101.X

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12828568